915 / 1224
/
/
CONCLUSIONS
• Initial results are promising in terms of
o
Biochemical response / control
o
GI Toxicity
• Increased rates of GU toxicity
• Un-answered questions
o
Clinical patient selection factors : P-Vol, IPSS, …
o
OAR tolerance doses
o
Prophylactic / premedication: tamsulosin, steroids …
o
Role in intermediate and high risk patients
o
Toxicity and biochemical control with sufficient FU
Should be practiced within prospective protocols
Matthias Guckenberger - DEGRO 2015
26
13.06.2016